Alnylam Pharmaceuticals
ALNY
#649
Rank
HK$240.49 B
Marketcap
HK$1,865
Share price
-7.14%
Change (1 day)
40.53%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Net assets

Net assets on the balance sheet as of September 2024 : HK$0.25 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company has HK$0.25 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alnylam Pharmaceuticals - Net assets on balance sheet (from 2003 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$-HK$1.73 Billion39.39%
2022-12-31$-HK$1.24 Billion-126.95%
2021-12-31$HK$4.58 B-41.78%
2020-12-31$HK$7.87 B-29.69%
2019-12-31$HK$11.20 B9.9%
2018-12-31$HK$10.19 B-26.12%
2017-12-31$HK$13.80 B93.4%
2016-12-31$HK$7.13 B-27.2%
2015-12-31$HK$9.80 B34.98%
2014-12-31$HK$7.26 B246.42%
2013-12-31$HK$2.09 B101.75%
2012-12-31$HK$1.03 B13.38%
2011-12-31$HK$0.91 B-25.57%
2010-12-31$HK$1.23 B-10.76%
2009-12-31$HK$1.37 B-11.65%
2008-12-31$HK$1.56 B0.58%
2007-12-31$HK$1.55 B-0.75%
2006-12-31$HK$1.56 B226.65%
2005-12-31$HK$0.47 B33.58%
2004-12-31$HK$0.35 B-273.22%
2003-12-31$-HK$0.21 Billion471.35%
2002-12-31$-HK$36.24 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
HK$2.63 B 947.70%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$228.31 B 90,540.72%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$9.50 B 3,674.09%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$10.86 B 4,212.67%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.76 B 203.46%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$338.20 B 134,167.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$609.22 B 241,760.67%๐Ÿ‡ซ๐Ÿ‡ท France
HK$49.70 B 19,631.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel